22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer

Stock Information for 22nd Century Group Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 22nd Century Group Inc

22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors
22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule
22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024
22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products
22nd Century Announces Plan to Eliminate Its Senior Secured Debt
22nd Century Group (XXII) Signs Large New CMO Customer
22nd Century Group (XXII) Reports Fourth Quarter 2023 Financial Results
22nd Century Group to Announce Fourth Quarter 2023 Results on March 28, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.